Auro Laboratories Ltd

₹ 198 -2.56%

24 Apr 3:21 p.m.

About

Incorporated in 1989, Auro Laboratories Limited is into the manufacturing of Active Pharmaceutical Ingredients (APIs), specializing in Diabetes therapy. The company also also undertakes Toll/Custom Manufacturing for API's and Intermediates on contract basis.
Key API Products of Auro Labs are:^[1]
- Metformin Hydrochloride
- Chlorzoxzone
- Chlorphenamine Maleate

Key Points

Product Portfolio:^[1]
a) Active Pharmaceutical Ingredients:
Anti-Diabetics, Anti-Histamines, Muscle Relaxants, Diuretics, Anti Fungal, Anti Ulcer, Anti Fungal, Anti Ulcer, Iodine Supplement, Iron Supplement, Anti Malaria, Analgesics, Antacids, Anti Inflammatory, Specialty Chemicals, etc.
b) Intermediates: ^[2]
Few Intermediates which are used in APIs are Glibenclamide, Ketoconazol, Sildenafil Citrate, and Citalopram

Website BSE

Market Cap ₹ 123 Cr.
Current Price ₹ 198
High / Low ₹ 210 / 63.0
Stock P/E 17.2
Book Value ₹ 59.4
Dividend Yield 0.00 %
ROCE 9.92 %
ROE 7.43 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Cons

Though the company is reporting repeated profits, it is not paying out dividend
The company has delivered a poor sales growth of 5.33% over past five years.
Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	13.11	13.56	10.53	10.32	12.14	17.88	11.19	12.56	15.62	13.52	10.18	13.41	17.98
	10.25	10.51	9.16	9.20	10.93	16.97	10.62	11.54	15.17	11.17	9.02	10.38	13.90
Operating Profit	2.86	3.05	1.37	1.12	1.21	0.91	0.57	1.02	0.45	2.35	1.16	3.03	4.08
OPM %	21.82%	22.49%	13.01%	10.85%	9.97%	5.09%	5.09%	8.12%	2.88%	17.38%	11.39%	22.60%	22.69%
	0.25	0.17	0.50	0.29	0.02	0.28	0.05	-0.16	0.43	0.62	0.36	0.32	0.42
Interest	0.05	0.25	0.11	0.15	0.16	0.40	0.26	0.32	0.10	0.13	0.27	0.35	0.44
Depreciation	0.26	0.28	0.26	0.26	0.26	0.24	0.25	0.25	0.27	0.30	0.27	0.27	0.27
Profit before tax	2.80	2.69	1.50	1.00	0.81	0.55	0.11	0.29	0.51	2.54	0.98	2.73	3.79
Tax %	27.50%	43.49%	29.33%	29.00%	24.69%	16.36%	27.27%	27.59%	27.45%	29.53%	27.55%	27.84%	27.70%
	2.03	1.52	1.07	0.71	0.61	0.46	0.08	0.21	0.37	1.78	0.71	1.97	2.73
EPS in Rs	3.26	2.44	1.72	1.14	0.98	0.74	0.13	0.34	0.59	2.86	1.14	3.16	4.38
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
	25.44	44.28	33.74	32.65	27.91	35.47	40.79	46.82	43.79	54.25	50.87	52.89	55.09
	23.33	41.01	30.95	29.71	25.11	31.03	34.43	39.83	37.51	43.01	46.24	48.50	44.47
Operating Profit	2.11	3.27	2.79	2.94	2.80	4.44	6.36	6.99	6.28	11.24	4.63	4.39	10.62
OPM %	8.29%	7.38%	8.27%	9.00%	10.03%	12.52%	15.59%	14.93%	14.34%	20.72%	9.10%	8.30%	19.28%
	0.05	0.06	0.06	0.24	0.42	0.53	0.51	0.96	0.97	0.76	1.09	0.94	1.72
Interest	1.43	1.85	1.53	1.66	1.66	1.18	1.21	0.87	0.58	0.46	0.83	0.81	1.19
Depreciation	0.47	0.72	0.74	0.72	0.68	0.86	0.93	1.01	1.02	1.04	1.02	1.07	1.11
Profit before tax	0.26	0.76	0.58	0.80	0.88	2.93	4.73	6.07	5.65	10.50	3.87	3.45	10.04
Tax %	0.00%	0.00%	0.00%	0.00%	0.00%	72.01%	25.16%	27.51%	27.96%	31.62%	26.61%	28.99%
	0.26	0.77	0.58	0.80	0.88	0.82	3.53	4.40	4.05	7.18	2.84	2.44	7.19
EPS in Rs	0.42	1.24	0.93	1.28	1.41	1.32	5.66	7.06	6.50	11.52	4.56	3.91	11.54
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	2%
5 Years:	5%
3 Years:	7%
TTM:	-4%

Compounded Profit Growth
10 Years:	12%
5 Years:	-7%
3 Years:	-16%
TTM:	542%

Stock Price CAGR
10 Years:	42%
5 Years:	25%
3 Years:	27%
1 Year:	211%

Return on Equity
10 Years:	17%
5 Years:	17%
3 Years:	14%
Last Year:	7%

Balance Sheet

Figures in Rs. Crores

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Sep 2023
Equity Capital	6.23	6.23	6.23	6.23	6.23	6.23	6.23	6.23	6.23	6.23	6.23	6.23	6.23
Reserves	-0.68	0.09	0.67	1.47	2.35	3.18	6.75	11.18	15.27	22.35	25.29	27.97	30.78
	15.94	16.75	14.80	16.41	12.62	4.95	9.20	8.09	3.16	3.16	13.78	6.41	15.35
	5.22	6.75	5.14	4.67	4.49	12.45	8.23	7.97	7.68	10.15	9.66	15.38	9.35
Total Liabilities	26.71	29.82	26.84	28.78	25.69	26.81	30.41	33.47	32.34	41.89	54.96	55.99	61.71
	6.38	10.68	10.51	9.80	9.13	13.00	13.02	14.59	14.24	13.56	13.61	12.62	12.15
CWIP	4.43	0.00	0.06	0.82	3.33	0.23	1.07	0.12	0.12	0.13	3.68	7.67	13.79
Investments	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05
	15.85	19.09	16.22	18.11	13.18	13.53	16.27	18.71	17.93	28.15	37.62	35.65	35.72
Total Assets	26.71	29.82	26.84	28.78	25.69	26.81	30.41	33.47	32.34	41.89	54.96	55.99	61.71

Cash Flows

Figures in Rs. Crores

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
	2.50	1.46	4.48	-0.78	7.88	6.49	6.05	6.87	9.30	12.82	-6.59	3.28
	-3.75	-0.52	-0.56	-0.73	-2.44	-2.20	-3.04	-3.19	-2.21	-3.51	-5.34	-5.08
	1.01	-0.79	-2.99	0.53	-5.34	-3.81	-1.77	-1.83	-5.52	-0.46	9.79	-8.18
Net Cash Flow	-0.24	0.15	0.93	-0.98	0.09	0.47	1.24	1.86	1.58	8.85	-2.14	-9.98

Ratios

Figures in Rs. Crores

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Debtor Days	42.47	66.52	46.95	94.80	66.04	79.13	74.90	66.26	48.18	49.12	97.65	85.57
Inventory Days	174.50	72.37	115.33	89.37	86.72	21.65	22.00	42.98	60.54	32.60	47.32	120.27
Days Payable	89.54	64.73	62.97	56.12	72.03	80.26	78.26	66.19	70.67	73.51	54.12	117.41
Cash Conversion Cycle	127.43	74.17	99.30	128.05	80.73	20.52	18.64	43.05	38.04	8.20	90.86	88.44
Working Capital Days	133.58	89.27	94.12	138.51	97.17	67.20	64.70	63.46	51.09	33.84	123.56	134.64
ROCE %	8.52%	11.71%	9.43%	10.74%	11.21%	23.06%	32.51%	29.11%	24.84%	38.87%	12.20%	9.92%

Shareholding Pattern

Numbers in percentages

3 Recently

	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	51.92%	51.93%	51.99%	51.99%	52.09%	52.09%	52.09%	52.09%	52.09%	52.09%	52.09%	52.15%
	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
	48.07%	48.06%	48.00%	48.00%	47.91%	47.91%	47.92%	47.90%	47.90%	47.92%	47.90%	47.85%
No. of Shareholders	9,377	10,129	10,189	11,340	11,362	11,183	11,135	10,906	10,501	10,272	9,905	9,441

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	51.23%	51.52%	51.89%	51.92%	51.92%	51.99%	52.09%	52.15%
	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
	48.76%	48.47%	48.10%	48.07%	48.07%	48.00%	47.90%	47.85%
No. of Shareholders	7,260	7,375	7,205	7,177	9,151	11,340	10,906	9,441

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Auro Laboratories Ltd

Auro Laboratories Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings